Literature DB >> 15348988

Third cranial nerve palsy from midbrain neurocysticercosis: repeated exacerbation on tapering corticosteroids.

Ji Soo Kim1, Seon-Mi Jeong, So Young Moon, Seong-Ho Park.   

Abstract

Third cranial nerve palsy is rare in neurocysticercosis and is usually caused by supratentorial or sub-arachnoid lesions with accompanying hydrocephalus or meningitis. We report a patient who presented with third cranial nerve palsy caused by neurocysticercosis involving the midbrain. The patient showed repeated exacerbation of symptoms on tapering corticosteroids. The experience with this patient indicates that tapering of corticosteroids should be performed very slowly in such cases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15348988     DOI: 10.1097/00041327-200409000-00007

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  8 in total

1.  Isolated third cranial nerve palsy: a rare presentation of neurocysticercosis.

Authors:  M P Ranjith; R Divya; A Sahni
Journal:  Ir J Med Sci       Date:  2009-04-02       Impact factor: 1.568

2.  The Eye Opener: Finding and Targeting the Midbrain Lesion.

Authors:  Aditya Choudhary; Rajveer Singh; Manoj Goyal; Manish Modi
Journal:  Neuroophthalmology       Date:  2018-01-09

3.  Bilateral ptosis: an atypical presentation of neurocysticercosis.

Authors:  Pravin Umakant Naphade; Maneesh Kumar Singh; Ravindra Kumar Garg; Dheeraj Rai
Journal:  BMJ Case Rep       Date:  2012-07-25

4.  Claude's syndrome associated with neurocysticercosis.

Authors:  Tae-Jin Song; Sang Hyun Suh; Hanna Cho; Kyung-Yul Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

5.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

6.  Cysticercosis of midbrain presenting with fluctuating ptosis.

Authors:  M Netravathi; A S Banuprakash; Renu Khamesra; N Hemantakumar Singh
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

7.  A "Cyst" in the Tale: Atypical Parinaud's Syndrome as a Heralding Feature of Midbrain Neurocysticercosis.

Authors:  Divyani Garg; Sagar Tomer; Rajiv Motiani
Journal:  Ann Indian Acad Neurol       Date:  2022-02-14       Impact factor: 1.714

8.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2018-04       Impact factor: 2.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.